T1	Intervention 33 127	granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation
T2	Intervention 224 229	PBSCT
T3	Intervention 312 408	high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT)
T4	Intervention 485 550	exogenous granulocyte colony-stimulating factor (G-CSF) treatment
T5	Intervention 596 601	PBSCT
T6	Intervention 770 784	primary PBSCT,
T7	Intervention 1068 1073	PBSCT
T8	Intervention 1213 1218	G-CSF
T9	Intervention 1259 1264	PBSCT
T10	Intervention 1280 1293	control group
T11	Intervention 1343 1535	high-dose regimens without total body irradiation consisted of the MCVAC regimen using ranimustine (MCNU, 450 mg/m2), cytosine arabinoside (16 g/m2), etoposide (1.6 g/m2), and cyclophosphamide
T12	Intervention 1579 1609	Hi-MEC regimen using melphalan
T13	Intervention 1623 1632	etoposide
T14	Intervention 1649 1662	carboplatinum
T15	Intervention 1853 1858	PBSCT
T16	Intervention 1729 1738	treatment
T17	Intervention 2063 2072	treatment
T18	Intervention 1937 1943	CFU-GM
T19	Intervention 2263 2268	PBSCT
T20	Intervention 2589 2594	PBSCT
T21	Intervention 2392 2399	control
T22	Intervention 2350 2359	treatment
T23	Intervention 2732 2739	control
T24	Intervention 2817 2826	treatment
T25	Intervention 3072 3111	between the G-CSF treatment and control
T26	Intervention 3372 3385	G-CSF therapy
T27	Intervention 3409 3414	PBSCT
